New Advances in the Diagnosis and Management of NASH (Regionals)
Credit(s): 1.00 (60 min)
November 2, 2022 - 7:00 - 8:00 PM ET
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
Non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease (NAFLD), is a severe liver disorder with a rapidly progressive course that can lead to liver fibrosis, cirrhosis, and hepatocellular carcinoma. In order to prevent irreversible liver damage, patients with NASH should receive immediate multidisciplinary care. However, distinguishing NASH from other liver disorders and identifying high-risk patients remains challenging. Additionally, once diagnosed, there is a dearth of effective, FDA approved treatment options for NASH, with lifestyle management and supportive care remaining the primary treatment modalities. In recent years, several novel agents have emerged as potential treatment options, backed by promising clinical safety and efficacy data.
This activity, New Advances in the Diagnosis and Management of NASH, will provide gastroenterologists and hepatologists with the latest information on how to screen for, diagnose, and risk stratify NASH and how to develop patient-personalized multidisciplinary treatment plans. Clinicians will also learn about novel agents in development for NASH, the clinical trial data supporting their use, and how best to integrate these agents into clinical practice as they become available.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Supported by an educational grant from Novo Nordisk.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Advances in Cancer Screening and Detection: What PCPs Need to Know
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.